Omada Health (OMDA) EBITDA (2024 - 2026)

Omada Health (OMDA) has 3 years of EBITDA data on file, last reported at -$4.8 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 43.06% year-over-year to -$4.8 million; the trailing twelve-month figure through Mar 2026 stood at -$8.4 million (up 75.46% YoY), and the FY2025 full-year result was -$12.0 million, up 72.58% from the prior year.
• EBITDA declined to -$4.8 million in Q1 2026, from $3.3 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $3.3 million in Q4 2025 to a low of -$10.0 million in Q2 2024.
• A 3-year average of -$5.3 million and a median of -$5.9 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA surged 146.21% in 2025 and jumped 43.06% in 2026, its largest moves.
• Tracing OMDA's EBITDA over 3 years: stood at -$7.1 million in 2024, then surged by 146.21% to $3.3 million in 2025, then slumped by 245.72% to -$4.8 million in 2026.
• Business Quant data shows OMDA's EBITDA at -$4.8 million in Q1 2026, $3.3 million in Q4 2025, and -$2.5 million in Q3 2025.